A joint initiative of the Centre for Biomedical Ethics (CBmE), NUS Medicine and the Patient Advocacy and Support Office (PASO), NUHS

Event

Two talks by Professor Mark Sheehan

Mark Sheehan, Ethox Centre and Uehiro Oxford Institute, University of Oxford

Hosted by the Centre for Biomedical Ethics and PACT Lab

Thursday 10 September 2026 · 12:30–2:00pm

The nature, role, and limits of PPI

Block MD11, 10 Medical Drive (room to be confirmed)

Friday 11 September 2026 · 12:30–2:00pm

Who and how do PPI contributors represent? Representation in patient and public involvement in health research

Block MD11, 10 Medical Drive (room to be confirmed)

Registration details to follow.

Mark Sheehan

Mark Sheehan

Speaker

Professor of Bioethics, Ethox Centre, University of Oxford; NIHR Biomedical Research Centre Oxford Ethics Fellow

Profile →
Michael Dunn

Michael Dunn

Respondent, 10 September

Associate Professor and Director of Education, Centre for Biomedical Ethics, NUS Medicine

Profile →

Professor Mark Sheehan visits the Centre for Biomedical Ethics on 10 and 11 September 2026 to give two talks on patient and public involvement in research. Both are hosted by the Centre for Biomedical Ethics and PACT Lab, and both are open to researchers, clinicians, students, and members of the public. Each talk runs around 35 to 40 minutes, followed by discussion. Registration details will be posted here shortly.

Thursday 10 September, 12:30–2:00pm — The nature, role, and limits of PPI

Funders across the United Kingdom now expect patient and public involvement in all research. Sheehan argues that the way to understand what involvement is for is to ask where it is not needed. Some cases arise from confusing involvement with ethics review, which asks whether a study is permissible rather than whether it is well designed for the people it affects. Others arise at the edges of the research enterprise: bench science, and abstract or theoretical work, where it is hard to say what involvement would contribute. Working through these cases yields a clearer account of the rationales for involvement in the cases where it does belong.

The talk also takes up two current shifts. The first concerns diversity and inclusion in involvement, which raises practical and philosophical questions about who is being included and on what basis. The second is terminological but consequential: the NIHR has replaced “patient and public involvement” with “community engagement and involvement”, a change that has caused disagreement and marks a further shift in how the activity is understood. Sheehan will also introduce his wider body of work on the ethics of involvement, and how he has built the involvement agenda in the medical sciences division at Oxford as an ethicist embedded in the Oxford Biomedical Research Centre.

A/Prof Michael Dunn will respond. Michael Dunn is Associate Professor and Director of Education at the Centre for Biomedical Ethics, and an Associate Faculty member at the Ethox Centre, Oxford, where he worked for over a decade. His research integrates philosophical, legal, and qualitative methods, with particular attention to people at the margins of society and to the nature and purpose of bioethical inquiry.

Friday 11 September, 12:30–2:00pm — Who and how do PPI contributors represent?

This standalone paper applies a distinction from political philosophy to patient and public involvement. Hannah Pitkin’s work in the 1960s separates being representative of a group, in the sense of resembling it or sharing its characteristics, from being a representative for a group, in the sense of acting on its behalf. The two come apart, and involvement practice often runs them together. Sheehan draws on empirical work with contributors about how they understand what they are doing.

About the speaker

Mark Sheehan is Professor of Bioethics at the Ethox Centre, University of Oxford, a Research Fellow at the Uehiro Oxford Institute, and NIHR Biomedical Research Centre: Oxford Ethics Fellow. His research addresses population-level health research and governance and public health ethics, including consent and governance in population-level research, trust and trustworthiness in healthcare institutions and in public attitudes research, and the nature and justification of patient and public involvement in research and health policy making. In his BRC role he works on research ethics, governance, and involvement across the Oxford BRC themes.

He is a National Research Ethics Advisor for the National Research Ethics Service, a member of the Ethics Review Advisory Group for the Health Research Authority’s Think Ethics programme, and a long-standing member of NICE’s Highly Specialised Technology Evaluation Committee. He has published in the Journal of Applied Philosophy, the Journal of Medical Ethics, the BMJ, and the American Journal of Bioethics. He received his PhD in philosophy from the City University of New York with a thesis on the nature of moral judgements.